PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- (ANI or the Company) (Nasdaq: ANIP) today announced that following final ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its price objective lifted by equities researchers at Truist Financial from $60.00 to $62.00 in a report released on Tuesday, Benzinga reports.

Two poster presentations demonstrate ANI’s commitment to research in membranous nephropathy carePRINCETON, N.J., Oct. 24, ...

One company value investors might notice is ANI Pharmaceuticals (ANIP). ANIP is currently holding a Zacks Rank of #1 (Strong Buy) and a Value grade of A. We should also highlight that ANIP has a P ...

Ratings for ANI Pharmaceuticals ANIP were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings ...

Piper Sandler started coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The firm issued an overweight ...

TATA AIG General Insurance Company Limited and Dun & Bradstreet India released the Horizon Watch Emerging Risk Report, a ...

India has emerged as a global leader in pharmaceuticals being the third-largest producer and a key supplier of generic medicines said Union Health Secretary P ...

Gujarat welcomed Spanish Prime Minister Pedro Sanchez Perez-Castejon on Thursday His visit for the inauguration of the Tata-Airbus manufacturing facility in ...

Despite signs of recovery in September export growth, challenges such as container shortages and geopolitical uncertainties ...

India stands poised to unlock an estimated USD 117 billion in untapped export potential as the upcoming World Trade Expo 2024 ...

ANI Pharmaceuticals (ANIP) announced that following final approval from the U.S. FDA for its Abbreviated New Drug Application, the company ...